Clinical studies recruiting near Wuxi

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Wuxi Second People's Hospital · Huabo Biopharm Co., Ltd. · NCT06592274 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Wuxi Peoples Hospital · Amgen · NCT07037433 Chinese Adults With Kidney Disease
Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT07522099 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Wuxi People's Hospital (Wuxi No.1 People's Hospital) · argenx · NCT06544499 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Wuxi People's Hospital · Eli Lilly and Company · NCT07369011 Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
Phase N/A · Wuxi Fifth People's Hospital · Huashan Hospital · NCT07694648 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0139 · Celgene · NCT05519085 The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors
NA · Wuxi People's Hospital · Wuxi People's Hospital · NCT06430515 Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
Phase 3 · Wuxi People's Hospital · Beletalent (Zhuhai) Pharmaceutical Co., Ltd · NCT06817265 The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management
NA · Research Site · AstraZeneca · NCT06909773 A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prost
Phase 1/Phase 2 · Affiliated Hospital of Jiangnan University · Yunhe Pharmaceutical (Tianjin) Co., Ltd · NCT06970119 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Wuxi People's Hospital · Takeda · NCT06963827 A Study of MI078 for Postpartum Depression
Phase 3 · Wuxi Mental Health Center · Nanjing Minova Pharmaceutical Co., Ltd. · NCT07721961 A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D
Phase 3 · Wuxi People's Hospital · Guangzhou Zhiyi Biotechnology Co., Ltd. · NCT06247046 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Wuxi 4th People's Hospital · Daiichi Sankyo · NCT06731478 Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
NA · The Second People's Hospital of Wuxi · Suzhou Hengruihongyuan Medical Technology Co. LTD · NCT07068438 Full-Course ECMO Strategy for Moderate-to-Severe ARDS
NA · Wuxi People's Hospital · Southeast University, China · NCT07726953 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Wuxi People's Hospital · Hoffmann-La Roche · NCT07351058 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Investigational Site Number: 1560018 · Sanofi · NCT07184931 3D1015 Injection for Patients With mCRPC
Phase 1 · Jiangnan University Affiliated Hospital · Chunjing Yu · NCT07537010 Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.
Phase 3 · Affiliated Hospital of Jiangnan University · Hangzhou Gensciences Biopharmaceutical Co., Ltd. · NCT07684898 Safety and Efficacy of Ventricular Irrigation for Ventriculitis
NA · 904 Hospital of the People's Liberation Army Joint Logistic · RenJi Hospital · NCT06358209 Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Phase 3 · Jiangnan University Medical Center · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07107256 Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema
Phase 3 · Wuxi Municipal People's Hospital · Bio-Thera Solutions · NCT07515079 Global Trial in APG2575 for Patients With CLL/SLL
Phase 3 · Ascentage Investigative Site · Ascentage Pharma Group Inc. · NCT06104566 A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate,
Phase 1 · Affiliated Hospital of Jiangnan University South Campus · BeOne Medicines · NCT06625593 Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
Phase 2 · Wuxi People's Hospital · Atom Therapeutics Co., Ltd · NCT07303777 CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
Phase 2 · Wuxi No.2 People's Hospital (Jiangnan University Medical Cen · Jinling Hospital, China · NCT07615348 Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)
Phase 4 · 904th Hospital of Joint Logistic Support Force of PLA · Second Affiliated Hospital of Nanchang University · NCT06284642 Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Affiliated hospital of Jiangnan university ( Site 0434) · Merck Sharp & Dohme LLC · NCT06136624

Look up another city

Look up another condition